IT1255450B - USE OF BILE ACIDS AS ANTI-VIRAL AGENTS - Google Patents

USE OF BILE ACIDS AS ANTI-VIRAL AGENTS

Info

Publication number
IT1255450B
IT1255450B ITMI921602A ITMI921602A IT1255450B IT 1255450 B IT1255450 B IT 1255450B IT MI921602 A ITMI921602 A IT MI921602A IT MI921602 A ITMI921602 A IT MI921602A IT 1255450 B IT1255450 B IT 1255450B
Authority
IT
Italy
Prior art keywords
bile acids
viral agents
agents
treatment
viral
Prior art date
Application number
ITMI921602A
Other languages
Italian (it)
Inventor
Fabio Berlati
Giancarlo Ceschel
Roberto Pellicciari
Celestino Ronchi
Original Assignee
Montefarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Montefarmaco Spa filed Critical Montefarmaco Spa
Priority to ITMI921602A priority Critical patent/IT1255450B/en
Publication of ITMI921602A0 publication Critical patent/ITMI921602A0/en
Priority to PCT/EP1993/001507 priority patent/WO1994000126A1/en
Publication of ITMI921602A1 publication Critical patent/ITMI921602A1/en
Application granted granted Critical
Publication of IT1255450B publication Critical patent/IT1255450B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Si descrive l'uso di acidi biliari e loro derivati solfati come agenti antivirali e un metodo per il loro impiego nel trattamento di affezioni erpetiche.The use of bile acids and their sulphate derivatives as antiviral agents and a method for their use in the treatment of herpetic diseases is described.

ITMI921602A 1992-06-30 1992-06-30 USE OF BILE ACIDS AS ANTI-VIRAL AGENTS IT1255450B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITMI921602A IT1255450B (en) 1992-06-30 1992-06-30 USE OF BILE ACIDS AS ANTI-VIRAL AGENTS
PCT/EP1993/001507 WO1994000126A1 (en) 1992-06-30 1993-06-15 The use of bile acids as antiviral agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921602A IT1255450B (en) 1992-06-30 1992-06-30 USE OF BILE ACIDS AS ANTI-VIRAL AGENTS

Publications (3)

Publication Number Publication Date
ITMI921602A0 ITMI921602A0 (en) 1992-06-30
ITMI921602A1 ITMI921602A1 (en) 1993-12-30
IT1255450B true IT1255450B (en) 1995-10-31

Family

ID=11363598

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921602A IT1255450B (en) 1992-06-30 1992-06-30 USE OF BILE ACIDS AS ANTI-VIRAL AGENTS

Country Status (2)

Country Link
IT (1) IT1255450B (en)
WO (1) WO1994000126A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646316A (en) * 1994-04-08 1997-07-08 Osteoarthritis Sciences, Inc. Bile acid inhibitors of metalloproteinase enzymes
DE19645044A1 (en) * 1996-10-31 1998-05-07 Falk Pharma Gmbh Use of ursodeoxycholic acid for the topical treatment of inflammatory diseases of the mucous membranes
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
BE1015498A5 (en) * 2003-04-28 2005-05-03 Mkm S C R L COMPOSITION AND USE OF THE IODE PUR DISSOLVED IN ESSENTIAL OIL MELALEUCA alternifolia AND / OR MELALEUCA quinquinervia.
JP6165843B2 (en) 2012-04-20 2017-07-19 オーエイチアール・ファーマシューティカル・インコーポレイテッドＯｈｒ Ｐｈａｒｍａｃｅｕｔｉｃａｌ，Ｉｎｃ． Aminosteroid compounds for the treatment of PTP1B related diseases
US20210346401A1 (en) * 2018-09-25 2021-11-11 Yichang Humanwell Pharmaceutical Co., Ltd Regulator of tgr5 signaling as immunomodulatory agent
CN115287268B (en) * 2022-05-19 2023-08-25 浙江大学 Method for proliferation of porcine acute diarrhea syndrome coronavirus on porcine intestinal organoids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431709A (en) * 1973-12-03 1976-04-14 Prodotti Antibiotici Spa Lysozyme derivatives
AU2272883A (en) * 1982-12-22 1984-06-28 Herpes Pharmaceutical Inc. Pharmaceutical compositions of steriods for treatment of herpes simplex infections
GB8417895D0 (en) * 1984-07-13 1984-08-15 Marples B A Pharmaceutical anti-fungal composition
GB8706313D0 (en) * 1987-03-17 1987-04-23 Health Lab Service Board Treatment & prevention of viral infections
NO178843C (en) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Process for the preparation of a pharmaceutical composition for the prevention of sexually transmitted diseases
JPH04500670A (en) * 1988-09-20 1992-02-06 フアイソンズ・ピーエルシー Methods and compositions for treating viral infections

Also Published As

Publication number Publication date
WO1994000126A1 (en) 1994-01-06
ITMI921602A1 (en) 1993-12-30
ITMI921602A0 (en) 1992-06-30

Similar Documents

Publication Publication Date Title
MXPA95001266A (en) Quinone derivatives and pharmacological use.
DE69031748D1 (en) Plasma treatment with metal mask integration
FI945362A (en) Method for preparation of monocyclopentadienyl metal complex compounds and method of use
ITMI921601A0 (en) USE OF NOR AND HOMO-DERIVATIVES OF BILE ACIDS AS PROMOTERS OF DRUG ABSORPTION
IT1217658B (en) PROCESS PERFECTED FOR THE PRODUCTION OF PERFLUOROPOLYETERS CONSTITUTED SUBSTANTIALLY BY PERFLUDOSSIETILENCHE AND PERFLUOROXIPROPYLENE UNITS
ITPD950090A0 (en) SUCCINIL HEAVY METAL SALTS DERIVATIVES OF HYALURONIC ACID AND THEIR USE AS POTENTIAL THERAPEUTIC AGENTS
BR9712685A (en) Vehicle wheel set having an ornamental surface treatment and manufacturing method of a vehicle wheel set having an ornamental surface treatment
PL310348A1 (en) Substituted derivatives of azolone for use in treating diseases caused by heliobacter
IT1255450B (en) USE OF BILE ACIDS AS ANTI-VIRAL AGENTS
ITMI930849A0 (en) PROCEDURE FOR THE APPLICATION OF METAL INTERLAYERS
GB2380939B (en) Treatment or prevention of auto-immune diseases
ATE114973T1 (en) HEPATOCYTE STIMULATING FACTOR.
NO178497C (en) Process for the preparation of 9-substituted guanine derivatives and intermediates for use in the process
IT1255486B (en) PROCESS FOR PREPARING BILIARY ACIDS CONJUGATED WITH TAURINE
BG102043A (en) Preparation of clavulanates
ATE107656T1 (en) PROCESS FOR THE PREPARATION OF 14-ALPHA-HYDROXY-4-ANDROSENE-3,6,17, TRION.
HU9500857D0 (en) Use of hyaluronic acid and forms to prevent arterial restenosis
AU7726087A (en) Platinum derivatives and cancer treatments
IT9086204A0 (en) METHOD FOR THE TREATMENT OF MALE ERECTIVE IMPOTENCE
FI925518A0 (en) Process for the preparation of therapeutically active 1-piperidinylalkanoylarylsulfonamide derivatives
FI945037A0 (en) Method of production of reproductive hormones
ITMI922766A0 (en) USE OF LYSOLECITHINS IN THE TREATMENT OF MALE IMPOTENCE AND ALOPECIA AND RELATED COMPOSITIONS SUITABLE FOR SUCH USE
FR2709964B1 (en) Antiviral pharmaceutical compositions proposed in the treatment of AIDS and Herpes.
ATE77744T1 (en) USE OF PYRROTHIDERIVATES.
FI945119A (en) Process for the preparation of 3 (S) -methylheptanoic acid and intermediates

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950627